ArticleInternational journal of clinical and experimental pathology2025
Intraductal papillary mucinous neoplasm of the intrahepatic bile duct: a case report and literature review.
Article in International journal of clinical and experimental pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is a rare malignant tumor originating from the bile duct epithelium, characterized by its ability to secrete large amounts of mucin, which can lead to biliary obstruction. This paper presents a case involving a 69-year-old woman presenting with intermittent right upper abdominal pain, imaging revealed dilation of the left intrahepatic bile duct and the presence of a solid mass. We performed left lateral hepatectomy on the patient, and the postoperative pathological diagnosis was intraductal papillary tumor with associated invasive carcinoma. At the 6-month postoperative follow-up, the patient showed no signs of recurrence and was in good condition. This case underscores the high malignant potential of IPMN-B, emphasizing the importance of early surgical resection following diagnosis to achieve a favorable prognosis and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.